The National Center for Advancing Translational Sciences at the National Institutes of Health has awarded nearly a half-million dollars to UCSF's Clinical and Translational Science Institute for a collaborative research project on oral cancer.
December 04, 2012
November 27, 2012
A team of researchers from UCSF and the University of Pennsylvania has uncovered how a normal biological mechanism called the “unfolded protein response,” goes awry in human lymphoma – work that may lead to the development of specific drugs to fight different forms of cancer.
September 28, 2012
September is National Childhood Cancer Awareness month, encouraging awareness and affirmation to the commitment of fighting pediatric cancer.
September 13, 2012
Biomedical researchers at UCSF have won five of 51 prestigious National Institutes of Health Director’s New Innovator awards for high-risk, high-reward research, each receiving up to $1.5 million over five years.
August 21, 2012
A proposed new treatment to help HIV/AIDS patients suffering from Kaposi’s sarcoma, the most common form of cancer in people with HIV, is now one step closer to becoming a reality thanks to a program that supports promising early-stage research.
August 08, 2012
Preliminary results of a recent study by Christina Baggott, a trained oncology nurse, found that children with cancer were significantly more likely to weigh in on their symptoms when using a kid-friendly touch-screen computer assessment tool, than the standard written checklist.
June 15, 2012
Vitamin D and calcium to prevent bone fractures in healthy, postmenopausal women does not work, at least at low supplemental doses, according to the United States Preventive Services Task Force.
April 02, 2012
Frank McCormick, director of the Helen Diller Family Comprehensive Cancer Center at UCSF and new president of the 35,000-member American Association of Cancer Research, discusses the state of cancer research.
March 05, 2012
Feng-Yen Li, a PhD candidate in biomedical sciences at UCSF, is among 13 graduate students from throughout North America chosen to receive the 2012 Harold M. Weintraub Graduate Student Award.
December 23, 2011
A cancer drug company founded by UCSF Professor Kevan Shokat, PhD, has been acquired by Japan-based Takeda Pharmaceuticals in an effort to add two novel drug projects to Takeda’s pipeline of potential oncology therapies.